3'-GESCHÜTZTE NUKLEOTIDE
European patent · EP3898643 · In force
Register entry
- Publication number
- EP3898643
- Application number
- EP19839220
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 16, 2019
- Published
- Oct 27, 2021
- Granted
- Apr 17, 2024
- Protection ends at the latest
- Dec 15, 2039
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C07H 19/02 (2006.01)C07H 21/04 (2006.01)C12Q 1/6869 (2018.01)C07H 19/10 (2006.01)C07H 19/20 (2006.01)C07H 23/00 (2006.01)
- Priority
- US 201862781638 P 19.12.2018
- PCT application
- PCT/US2019/066670 16.12.2019
- PCT publication
- WO2020/131759 25.06.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Feb 26, 2025
Change
Published in Swissreg on 26.02.2025
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Apr 17, 2024
Granted
Published in Swissreg on 17.04.2024
Parties
Inventor
KHAKSHOOR, Omid
Pleasanton, California 94588, US
CRISALLI, Peter
Pleasanton, California 94588, US
HEINDL, Dieter
Penzberg 82377, DE
TAING, Meng
Pleasanton, California 94588, US
BERGMANN, Frank
Penzberg 82377, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.